本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Janux Therapeutics, Inc.

28.72
-0.5600-1.91%
盘后28.760.0400+0.14%18:57 EST
成交量:92.68万
成交额:2,688.85万
市值:17.27亿
市盈率:-17.09
高:29.94
开:28.95
低:28.34
收:29.28
52周最高:71.71
52周最低:21.73
股本:6,014.78万
流通股本:4,496.69万
量比:1.13
换手率:2.06%
股息:- -
股息率:- -
每股收益(TTM):-1.6802
每股收益(LYR):-1.2836
净资产收益率:-12.48%
总资产收益率:-10.49%
市净率:1.77
市盈率(LYR):-22.38

数据加载中...

2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/01

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/09/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/09

重要事件披露

Form 8-K - Current report
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/07/19

重要事件披露

Form 8-K - Current report
2023/07/17

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/07/17

重要事件披露

Form 8-K - Current report
2023/07/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/24

重要事件披露

Form 8-K - Current report
2023/06/21

重要事件披露

Form 8-K - Current report
2023/05/31

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/09

重要事件披露

8-K - Current report